HIGHLIGHTS
- who: Shuhang Wang and collaborators from the NHC Key Laboratory of Pulmonary Immunological Diseases, Guizhou Provincial People's Hospital, Beijing, China have published the research work: Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development, in the Journal: Vaccines 2022, 10, x FOR PEER REVIEW of 10/01/2022
- what: This study is designed to identify MESO antigens that have the potential for mRNA vaccine development and to determine the immune subtypes for the selection of suitable patients. In this study, the association between the previously described C1-C6 pan . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.